Competitor Analysis- Cancer Vaccines

The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. "Competitor Analysis- Cancer Vaccines" report includes a compilation of currently active projects in research and development for prophylaxis and therapy of cancer.Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major pharmaceutical markets with combined 2013 sales of US$ 2,385 mln.